Health ❯ Diseases

Lung Diseases

Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Pulmonary Hypertension Lung Fibrosis Emphysema Interstitial Lung Disease (ILD) Fibrosis Chronic Lung Conditions Impact on Athletes Tobacco-Related Illnesses Silicosis Chronic Illness Interstitial Lung Disease

GSK to Acquire 35Pharma for $950 Million to Add Pulmonary Hypertension Candidate HS235

The signed deal would place an activin‑pathway therapy with phase 1 data into GSK’s RI&I pipeline pending U.S. and Canadian clearance.

Massachusetts Confirms First Silicosis Case Tied to Countertop Work, Issues Safety Alert

AI-Designed Rentosertib Improves Lung Function in Phase IIa IPF Trial